Skip to main content

Whitehawk Therapeutics, Inc.

WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422142

No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Whitehawk Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of WHWK: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders68680
Shares13.2M15.1M+1.83M (+13.8%)
Value$159.3M$212.1M+$52.9M (+33.2%)

New holders (11)

Institutions that held Whitehawk Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to WHWK in Q3 2022
InstitutionSharesValue% of portfolio
Baker Bros. Advisors LP989,928$14.0M0.09%
Ally Bridge Group (NY) LLC124,625$1.76M1.16%
Schonfeld Strategic Advisors LLC77,400$320.0K0.00%
Jump Financial, LLC19,300$273.0K0.01%
Squarepoint Ops LLC16,317$231.0K0.00%
Trexquant Investment LP12,847$182.0K0.01%
BNP Paribas Arbitrage, SA10,350$146.2K0.00%
XTX Topco Ltd10,306$146.0K0.04%
Bartlett & Co. LLC1,333$19.0K0.00%
Bartlett & Co. Wealth Management LLC1,333$18.8K0.00%
Simplex Trading, LLC92$1.00K0.00%

Sold out (11)

Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of WHWK in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
VR Adviser, LLC1,173,518$14.5M
Ikarian Capital, LLC412,343$1.27M
Susquehanna International Group, LLP30,306$373.0K
Marshall Wace, LLP19,564$242.0K
Rafferty Asset Management, LLC17,839$220.0K
UBS Group AG16,434$202.0K
Boothbay Fund Management, LLC12,721$157.0K
D. E. Shaw & Co., Inc.11,395$140.0K
MetLife Investment Management7,802$96.1K
Metropolitan Life Insurance Co906$11.2K
Captrust Financial Advisors404$5.00K